Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 7, 2014, Pages 1407-1416

  Cai, Benzhi ^a   Wang, Gang ^a   Chen, Nan ^a   Liu, Yanju ^a   Yin, Kun ^a   Ning, Chunping ^a   Li, Xingda ^a   Yang, Fan ^a   Wang, Ning ^a   Wang, Yang ^a   Pan, Zhenwei ^a   Lu, Yanjie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmias; Bone marrow mesenchymal stem cells; Calcineurin; Myocardial infarction; Potassium channels

Indexed keywords

CALCIUM; POTASSIUM CHANNEL; PROTECTIVE AGENT;

ANIMAL; ARRHYTHMIAS, CARDIAC; BONE MARROW CELL; CELL CULTURE; CONGENITAL MALFORMATION; CYTOLOGY; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; ARRHYTHMIAS, CARDIAC; BLOTTING, WESTERN; BONE MARROW CELLS; CALCIUM; CELLS, CULTURED; ECHOCARDIOGRAPHY; HEART CONDUCTION SYSTEM; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; POTASSIUM CHANNELS; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84904906659     PISSN: 15821838     EISSN: 15824934     Source Type: Journal    
DOI: 10.1111/jcmm.12287     Document Type: Article

References (38)

1. Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007; 4: S21-6.
2. Nagaya N, Kangawa K, Itoh T, et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation. 2005; 112: 1128-35.
3. Gaebel R, Furlani D, Sorg H, et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS ONE. 2011; 6: e15652.
4. Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005; 11: 367-8.
5. Yang YJ, Qian HY, Huang J, et al. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J. 2008; 29: 1578-90.
6. Ripa RS, Haack-Sorensen M, Wang Y, et al. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation. 2007; 116: I24-30.
7. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005; 102: 11474-9.
8. English K, French A, Wood KJ. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell. 2010; 7: 431-42.
9. Volarevic V, Arsenijevic N, Lukic ML, et al. Concise review: mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells. 2011; 29: 5-10.
10. Zhang N, Li J, Luo R, et al. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes. 2008; 116: 104-11.
11. Ohnishi S, Yanagawa B, Tanaka K, et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol. 2007; 42: 88-97.
12. Mias C, Lairez O, Trouche E, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009; 27: 2734-43.
13. Schuleri KH, Feigenbaum GS, Centola M, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009; 30: 2722-32.
14. Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009; 54: 2277-86.
15. Williams AR, Trachtenberg B, Velazquez DL, et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res. 2011; 108: 792-6.
16. Lu Z, Abe J, Taunton J, et al. Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity. Circ Res. 2008; 103: 269-78.
17. Guo W, Jung WE, Marionneau C, et al. Targeted deletion of Kv4.2 eliminates I(to, f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res. 2005; 97: 1342-50.
18. + channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol. 2000; 11: 1252-61.
19. Benzhi C, Limei Z, Ning W, et al. Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. J Mol Cell Cardiol. 2009; 47: 41-8.
20. Pan Z, Zhao W, Zhang X, et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFbeta1 expression and activation of p38-MAPK and ERK1/2. Br J Pharmacol. 2011; 162: 688-700.
21. Lu Y, Zhang Y, Shan H, et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res. 2009; 84: 434-41.
22. Biala A, Finckenberg P, Korpi A, et al. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats. J Physiol Pharmacol. 2011; 62: 275-85.
23. Cai B, Gong D, Chen N, et al. The negative inotropic effects of homocysteine were prevented by matrine via the regulating intracellular calcium level. Int J Cardiol. 2011; 150: 113-5.
24. Cai B, Shan L, Gong D, et al. Homocysteine modulates sodium channel currents in human atrial myocytes. Toxicology. 2009; 256: 201-6.
25. Shan H, Li X, Pan Z, et al. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br J Pharmacol. 2009; 158: 1227-35.
26. Huang B, Qin D, El-Sherif N. Early down-regulation of K+ channel genes and currents in the postinfarction heart. J Cardiovasc Electrophysiol. 2000; 11: 1252-61.
27. Nattel S, Maguy A, Le Bouter S, et al. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007; 87: 425-56.
28. Rossow CF, Dilly KW, Santana LF. Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res. 2006; 98: 1306-13.
29. Rossow CF, Dilly KW, Yuan C, et al. NFATc3-dependent loss of I(to) gradient across the left ventricular wall during chronic beta adrenergic stimulation. J Mol Cell Cardiol. 2009; 46: 249-56.
30. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007; 25: 2896-902.
31. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med. 2007; 2: 63-8.
32. Wang D, Zhang F, Shen W, et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol. 2011; 152: 314-20.
33. Ly HQ, Nattel S. Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation. 2009; 119: 1824-31.
34. Pijnappels DA, Schalij MJ, van Tuyn J, et al. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res. 2006; 72: 282-91.
35. + currents after myocardial infarction. Circ Res. 2004; 94: 1340-50.
36. 2+ signal integrators. Proc Natl Acad Sci USA. 2008; 105: 2859-64.
37. 2+, calcineurin, and NF-AT. Cell. 1999; 96: 611-4.
38. Pike GK, Bretag AH, Roberts ML. Modification of the transient outward current of rat atrial myocytes by metabolic inhibition and oxidant stress. J Physiol. 1993; 470: 365-82.